# Effects of Black Cumin Seed Extract on Pancreatic Islet β-Cell Proliferation and Hypoglycemic Activity in Streptozotocin-Induced Diabetic Rats

**Authors:** Jongkyu Kim, Yoon-Seok Chun, Namkyu Yoon, Byungkwon Kim, Kiin Choi, Sae-Kwang Ku, Namju Lee

PMC · DOI: 10.3390/antiox14020174 · Antioxidants · 2025-01-31

## TL;DR

Black cumin seed extract improves pancreatic function and reduces hyperglycemia in diabetic rats, offering a potential natural treatment for diabetes.

## Contribution

The study demonstrates the long-term safety and efficacy of black cumin seed extract in managing diabetes and its complications.

## Key findings

- BCS administration improved organ weight and suppressed genes linked to pancreatic damage.
- BCS effectively regulated chronic and acute hyperglycemia in diabetic rats.
- The extract showed potential for managing both glycemic and non-glycemic diabetes complications.

## Abstract

Thymoquinone (TQ), a bioactive compound derived from black cumin seeds, is renowned for its potent anti-obesity and anti-diabetic properties. Due to the stability challenges of TQ, it has predominantly been utilized in oil formulations. This study aimed to enhance the stability of TQ and investigated the impact of consuming insoluble fiber from black cumin seeds on restoring antioxidant function compromised by diabetes and improving hyperglycemia management. We evaluated the restorative effects of a 35-day administration of black cumin seed extract (BCS) on antioxidant function impaired by streptozotocin (STZ)-induced diabetes, alongside structural and functional alterations in the pancreas, liver, and kidneys. The results demonstrated significant improvements in organ weight, particularly in pancreatic tissue. Moreover, BCS administration markedly suppressed the expression of key genes associated with pancreatic dysfunction and damage, including caspase-3, transforming growth factor-beta 1 (TGF-β1), and interleukin-1 beta (IL-1β). Through oral glucose tolerance tests (OGTTs), BCS was found to effectively regulate chronic hyperglycemia and exhibit potential for managing acute hyperglycemia. These findings suggest that BCS not only addresses both glycemic and non-glycemic complications of diabetes but also offers a safe, long-term solution. Consequently, BCS emerges as a promising therapeutic agent for hyperglycemia management, including in prediabetic stages.

## Linked entities

- **Genes:** Casp3 (caspase 3) [NCBI Gene 12367], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], IL1B (interleukin 1 beta) [NCBI Gene 3553]
- **Chemicals:** Thymoquinone (PubChem CID 10281)
- **Diseases:** diabetes (MONDO:0005015), hyperglycemia (MONDO:0002909)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** Diabetic (MESH:D003920), pancreatic dysfunction and damage (MESH:D010182), hyperglycemia (MESH:D006943), obesity (MESH:D009765)
- **Chemicals:** glucose (MESH:D005947), BCS (-), oil (MESH:D009821), STZ (MESH:D013311), TQ (MESH:C003466)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11852139/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11852139/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC11852139/full.md

---
Source: https://tomesphere.com/paper/PMC11852139